top of page

Accelerating Health Cures, Therapies and Intelligence



Clinical Research AcceleratorTM

AMBITNA accelerates bringing new therapies to market faster by automatically matching more diverse, eligible patients to trials and sites



Only 4-8% of ELIGIBLE patients ACCESS clinical research...

AMBITNA automatically and securely connects eligible patients with their providers to researchers for faster discovery of cures with security, privacy, and distributed analytics.

Patients and their providers automatically know what is accessible to accelerate a cure and extend a life.

What We Offer


With AMBITNA, a more diverse population can participate in clinical research.


Presently, minorities and women are under-represented in clinical trials. This represents a delay to the approval of drugs, understanding of all side effects and true dosing. It also increases the chances that after approval, the number of side effects, complications and dosing issues create a major liability burden for the pharmaceutical and the health care system involved.



AMBITNA uses military-grade security to protect patient and clinical trial data at rest and in motion with a technology fabric that does not require data to be centrally stored to provide the AI to securely connect patients and providers to clinical trials.


AMBITNA saves time and money to identify and enroll eligible patients in research. 


  • Pharma can accelerate the regulatory approval process; increase the cohort of patient pools with more diversity on gender, race, ethnicity and age thus decreasing liability; and increase ROI while mitigating product liability.

  • Improving health outcomes faster saves both the patient and payor.

  • Clinicians and academic medical centers now have the opportunity to increase knowledge, quality of care offerings and expansion of services plus gain on revenue from research.



Deep Industry Knowledge

AMBITNA founders and partners have been at the forefront of breakthroughs in cancer prevention and control and innovations safely commercialized from diverse clinical trials at leading cancer centers and health systems.

Technology Innovation Differentiators

  • Federated peer-to-peer network allows each data owner to retain their data and its control at all times
  • Military grade encryption secures data at rest and in motion with data sharding 
  • AI automates matching of patients to studies
  • Blockchain audit for secure distributed analytics without centralizing the source data
  • Providers automatically have eligible trial notification in their EHR for the specific patient to discuss enrollment
Why Us


  • LinkedIn
  • Twitter

Thanks for submitting!

Contact Us

Offices in: 

Washington, D.C.

Nashville, TN

Bellevue, WA

Los Angeles, CA

bottom of page